Fmr LLC acquired a new position in shares of Amentum Holdings, Inc. (NYSE:AMTM – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 79,315 shares of the company’s stock, valued at approximately $2,558,000.
Several other hedge funds and other institutional investors also recently modified their holdings of AMTM. Primecap Management Co. CA acquired a new stake in Amentum during the third quarter worth about $169,999,000. Allspring Global Investments Holdings LLC bought a new position in Amentum during the 3rd quarter worth $78,399,000. Massachusetts Financial Services Co. MA acquired a new stake in Amentum in the third quarter worth $39,613,000. Charles Schwab Investment Management Inc. bought a new stake in Amentum in the third quarter valued at $24,527,000. Finally, Thrivent Financial for Lutherans bought a new position in shares of Amentum during the third quarter worth about $17,268,000. Institutional investors own 39.93% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on AMTM. Raymond James initiated coverage on Amentum in a report on Thursday, November 21st. They set an “outperform” rating and a $30.00 price target on the stock. Truist Financial assumed coverage on Amentum in a research report on Monday, October 14th. They set a “buy” rating and a $31.00 price target for the company.
Amentum Price Performance
AMTM stock opened at $23.05 on Friday. The business has a 50 day moving average of $27.07. Amentum Holdings, Inc. has a 12-month low of $21.24 and a 12-month high of $34.50.
About Amentum
Amentum Holdings, Inc provides engineering and technology solutions to address challenges in science, security, and sustainability. It serves various markets, such as energy and environment, space, intelligence, defense, civilian, commercial, and international markets. The company was incorporated in 2010 and is headquatered in Chantilly, Virginia.
Featured Stories
- Five stocks we like better than Amentum
- How to Calculate Inflation Rate
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Invest in Biotech Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Best Stocks Under $10.00
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Amentum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amentum and related companies with MarketBeat.com's FREE daily email newsletter.